GLP-1s Tied to Big Survival Advantage in Colon Cancer Patients

(MedPage Today) — Patients with colon cancer and a history of treatment with GLP-1 receptor agonists for obesity had a 5-year mortality rate that was less than half the rate for patients who didn’t take these drugs, according to a large retrospective…